Latest News

Cancer drugs block dementia-linked brain inflammation, study finds

A class of drugs developed to treat immune-related conditions and cancer -- including one currently in clinical trials for glioblastoma and other tumors -- eliminates neural inflammation associated with dementia-linked diseases and brain injuries, according to researchers. In their study, the researchers discovered that the drugs, which can be delivered orally, eradicated microglia, the primary immune cells of the brain. These cells exacerbate many neural diseases, including Alzheimer's and Parkinson's, as well as brain injury.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Hugs help protect against stress, infection, say researchers

  • Can poor sleep lead to dementia?

  • Drugs used for impotence could treat vascular dementia?

  • The sense of smell uses fast dynamics to encode odors

  • Neuronal circuits filter out distractions in brain

  • Therapeutic strategy may treat childhood neurological disorder

  • Immune cells in brain respond to fat in diet, causing mice to eat

  • Myelin linked to speedy recovery of human visual system after tumor removal

  • Progesterone offers no significant benefit in traumatic brain injury clinical trial

  • New way to diagnose brain damage from concussions, strokes, and dementia

  •